TCL Archive Coulter And Venture Capital Firm Form Company To Develop B1 Antibody For NHL April 28, 1995
TCL Archive Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate March 25, 2011
TCL Archive NCI, NIH Make Half-Hearted Pitch For Cancer Act Before Seemingly Uninterested Rogers Committee March 10, 1978
TCL Archive Volasertib Shows Response In 31 Percent of Acute Myeloid Leukemia Patients December 28, 2012
